Revisiting inconsistency in large pharmacogenomic studies [version 3; referees: 2 approved, 1 approved with reservations]

Revisiting inconsistency in large pharmacogenomic studies [version 3; referees: 2 approved, 1 approved with reservations]

In 2013, we published a comparative analysis of mutation and gene expression profiles and drug sensitivity measurements for 15 drugs characterized in the 471 cancer cell lines screened in the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE). While we found good...

Full description

Bibliographic Details
Main Authors: Zhaleh Safikhani, Petr Smirnov, Mark Freeman, Nehme El-Hachem, Adrian She, Quevedo Rene, Anna Goldenberg, Nicolai J. Birkbak, Christos Hatzis, Leming Shi, Andrew H. Beck, Hugo J.W.L. Aerts, John Quackenbush, Benjamin Haibe-Kains
Format: Article
Language:English
Published: F1000 Research Ltd 2017-08-01
Series:F1000Research
Subjects:
Cancer Therapeutics
Drug Discovery & Design
Methods for Diagnostic & Therapeutic Studies
Pharmacogenomics
Online Access:https://f1000research.com/articles/5-2333/v3

Internet

https://f1000research.com/articles/5-2333/v3

Similar Items